Inauguration

Coffee Break and Networking

Networking Dinner

Technology Spotlight:
Accelerate Your Drug Discovery Process with Maybridge Screening Collections and Fragment Libraries
Simon Pearce, Global Product Manager, ThermoFisher Scientific

Technology Spotlight:
Automation Tools for Drug Discovery
Basavaraj Gadag, Director, eDiscovery Automation Pvt Ltd

Coffee Break and Networking in Exhibition Area

Future Trends and Challenges in Innovative Translational Research: Academic and Industrial Perspective
G Praveen Kumar, Professor & Principal, Sahasra Institute of Pharmaceutical Sciences, India

This talk highlights the current state of translational research worldwide including what academia and industry should do in order to achieve better, faster translational results for the benefit of both patients and themselves.

Lunch Break and Networking in Exhibition Area

Cytokines and their Signalling Pathways as Therapeutic Targets in Drug Discovery for Inflammatory Disorders: Focus on Atherosclerosis
Dipak Ramji, Professor, Cardiff University, United Kingdom

This talk will elaborate the Novel insights into intracellular signalling pathways. Cytokines will be discussed in the context of current therapies and future drug discovery and development. In this presentation many conventional therapies, such as statins and nutraceuticals, that modulate cytokine signalling will also be discussed. The limitation of cytokine therapeutics and the possibility of approaches involving modulation of cells that produce anti-atherogenic cytokines will also be presented.

Coffee Break and Networking in Exhibition Area

Current Status of Computational Drug designing and Challenges for Next Millennium
Prakash Jha, Assistant Professor, Central University of Gujarat, India

Role of Polymorphs in Drug Discovery
Keshav Deo, Senior Vice President, Wockhardt Research Center, India

Pre-clinical Drug Development
Punit Srivastava, Assistant Director, Daiichi Sankyo India Pharma Pvt Ltd, India

ADMET Technologies in Drug Design and Discovery: Helping the Medicinal Chemist in Optimal Drug Design
Subrahmanyam Vangala, Founder and Chief Executive Officer, ReaGene Biosciences Private Limited, India

This talk will focus on how ADMET technologies have evolved in the past twenty years while becoming very critical for Medicinal Chemists to design novel NCEs.

Coffee Break and Networking in Exhibition Area

Novel Screening Methodologies for Drug Discovery
Rakesh Rawal, Senior Scientific Officer & Head, The Gujarat Cancer & Research Institute, India

Fragment Based Approaches in Drug Discovery
Sridhar Radhakrishnan , Research Fellow , Cancer Science Institute of Singapore , Singapore

Pharmaceutical Industries Continued Love Affair with Cholestrol
Shanavas Alikunju, Vice President & Head - Translational R&D and Biology, Dr. Reddy's Laboratories Ltd, India

Poster Viewing

Lunch Break and Networking in Exhibition Area

Design and Synthesis of Novel Therapeutic Agents
Prem M S Chauhan, Professor (AcSIR), Central Drug Research Institute, India

This presentation highlights about the development of biologically active scaffolds as antiparasitic agents. The design, synthesis and antiparasitic activity of the novel therapeutic agents will also be discussed.

Discovery Approaches for Neglected Tropical Diseases
Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India

Coffee Break and Networking in Exhibition Area

Panel Discussion